placebo p

Related by string. * placebos . Placebo . Placebos . PLACEBO : blind placebo controlled . placebo controlled clinical trials . randomized placebo controlled . double blind placebo . blinded placebo controlled . placebo controlled . blind randomized placebo / PS . PD . Ping . P. . Per . Ps : & P . Earnings Per Share . Ten Per Cent . Pay Per View . Pay Per Click . Per Cent Stake * placebo p = *

Related by context. Frequent words. (Click for all words.) 83 placebo p = 73 statistically significant p 70 p = #.# [002] 70 P = .# 70 p = #.# [004] 69 placebo 68 p = 65 log# 63 Secondary endpoints included 63 tiotropium 62 confidence interval CI 62 quetiapine 62 mg d 62 unfractionated heparin 62 glimepiride 62 mg BID 61 mg dose 61 demonstrated statistically significant 61 peginterferon alfa 2a 61 secondary endpoint 60 mmol L 60 statistically significant reduction 60 LVEF 60 mg kg 60 bosentan 60 adalimumab 59 % CI #.#-#.# [006] 59 IU mL 59 insulin glargine 59 HbA1c levels 59 median PFS 59 % CI #.#-#.# [002] 59 statistically significant improvement 59 dyspnea 59 febrile neutropenia 59 symptom severity 59 FEV1 59 mg dL 59 peripheral edema 58 primary efficacy endpoint 58 creatinine clearance 58 nasopharyngitis 58 ACR# [002] 58 Secondary endpoints 58 certolizumab pegol 58 Secondary endpoints include 58 pramipexole 58 copies mL 58 nonsignificant 58 HbA1c 58 etanercept 58 treatment emergent adverse 57 mitoxantrone 57 sustained virologic response 57 μg 57 CI = 57 g dL 57 fasting plasma glucose 57 enoxaparin 57 sinus rhythm 57 fluticasone 57 lamotrigine 57 FOLFOX 57 secondary endpoints 57 mg doses 56 primary endpoint 56 azathioprine 56 leukopenia 56 ng mL 56 pioglitazone 56 plus ribavirin 56 mm Hg 56 olanzapine 56 statistically significant 55 achieve statistical significance 55 composite endpoint 55 bivalirudin 55 valsartan 55 LMWH 55 haloperidol 55 pruritus 55 ramipril 55 Median survival 55 pregabalin 55 belimumab 55 55 infliximab 54 evaluable 54 linezolid 54 ticagrelor 54 Adverse events 54 n = 54 lacosamide 54 events AEs 54 target lesion revascularization 54 thromboembolism 54 free survival PFS 54 HCV RNA 54 risperidone 54 dexamethasone 54 df =

Back to home page